By studying tissue samples from 80 breast cancer patients (invasive ductal carcinoma, clinical-stage II-III) diagnosed by puncture biopsy, breast cancer patients with low TRAF4 expression benefited most from chemotherapy (50). This evidence concerns the gene TRAF4 and invasive ductal breast carcinoma.